Human Genome exchanges $77.53 million of 2.25% convertibles for stock

By Marisa Wong

Madison, Wis., Aug. 1 - Human Genome Sciences, Inc. issued common stock to holders of its 2.25% convertible subordinated notes due 2011 in exchange for $77,528,000 principal amount of the notes, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company issued a total of 5,026,743 shares of common stock in several separate transactions on July 29.

Human Genome Sciences is a Rockville, Md., biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.